Original language | English |
---|---|
DOIs | |
Publication status | Published - Apr 2017 |
Elbasvir/Grazoprevir Plus Sofosbuvir in Treatment-Naive and Treatment-Experienced Cirrhotic Patients with Hepatitis C Virus Genotype 3 Infection Treated for 8, 12 or 16 Weeks: Final Results of the C-ISLE Study
B Haber, GR Foster, K Agarwal, ME Cramp, S Moreea, S Barclay, J Collier, AS Brown, SD Ryder, A Ustianowski, D Forton, R Fox, F Gordon, W Rosenberg, DJ Mutimer, J Du, CL Gilbert, M Robertson, E Barr
Research output: Contribution to conference › Conference paper (not formally published) › peer-review